121 related articles for article (PubMed ID: 10477164)
1. Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma.
Kollmannsberger C; Brugger W; Hartmann JT; Maurer F; Böhm P; Kanz L; Bokemeyer C
Anticancer Drugs; 1999 Jun; 10(5):453-6. PubMed ID: 10477164
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas.
Hartmann JT; Oechsle K; Mayer F; Kanz L; Bokemeyer C
Anticancer Res; 2003; 23(2C):1899-901. PubMed ID: 12820475
[TBL] [Abstract][Full Text] [Related]
3. Oral trofosfamide: an active and well-tolerated maintenance therapy for adult patients with advanced bone and soft tissue sarcomas. Results of a retrospective analysis.
Reichardt P; Pink D; Tilgner J; Kretzschmar A; Thuss-Patience PC; Dörken B
Onkologie; 2002 Dec; 25(6):541-6. PubMed ID: 12566899
[TBL] [Abstract][Full Text] [Related]
4. Oral trofosfamide: an active drug in the treatment of soft-tissue sarcoma.
Blomqvist C; Wiklund T; Pajunen M; Virolainen M; Elomaa I
Cancer Chemother Pharmacol; 1995; 36(3):263-5. PubMed ID: 7781149
[TBL] [Abstract][Full Text] [Related]
5. Randomised phase II trial of trofosfamide vs. doxorubicin in elderly patients with untreated metastatic soft-tissue sarcoma.
Hartmann JT; Kopp HG; Gruenwald V; Piperno-Neumann S; Kunitz A; Hofheinz R; Mueller L; Geissler M; Horger M; Fix P; Chemnitz JM; Neise M; Wehler T; Zander I; Eckert R; Hann von Weyhern C; Bauer S; Mayer F;
Eur J Cancer; 2020 Jan; 124():152-160. PubMed ID: 31785463
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone and rofecoxib combined with angiostatically scheduled trofosfamide in the treatment of far-advanced melanoma and soft tissue sarcoma.
Reichle A; Bross K; Vogt T; Bataille F; Wild P; Berand A; Krause SW; Andreesen R
Cancer; 2004 Nov; 101(10):2247-56. PubMed ID: 15470711
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracil.
Strumberg D; Harstrick A; Klaassen U; Müller C; Eberhardt W; Korn MW; Wilke H; Seeber S
Anticancer Drugs; 1997 Mar; 8(3):293-5. PubMed ID: 9095336
[TBL] [Abstract][Full Text] [Related]
8. Combination of 5-fluorouracil, adriamycin, ifosfamide and cisplatin in metastatic adult soft tissue sarcoma: results of a phase II study.
Jäger E; Klein O; Wächter B; Bernhard H; Dippold W; Meyer zum Büschenfelde KH; Knuth A
Oncology; 1996; 53(1):58-63. PubMed ID: 8570133
[TBL] [Abstract][Full Text] [Related]
9. High-dose ifosfamide as second- or third-line chemotherapy in refractory bone and soft tissue sarcoma patients.
Lee SH; Chang MH; Baek KK; Han B; Lim T; Lee J; Park JO
Oncology; 2011; 80(3-4):257-61. PubMed ID: 21734417
[TBL] [Abstract][Full Text] [Related]
10. Palliative chemotherapy in non-Hodgkin's lymphoma.
Salminen E; Nikkanen V; Lindholm L
Oncology; 1997; 54(2):108-11. PubMed ID: 9075780
[TBL] [Abstract][Full Text] [Related]
11. A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas.
Garcia del Muro X; Lopez-Pousa A; Martin J; Buesa JM; Martinez-Trufero J; Casado A; Poveda A; Cruz J; Bover I; Maurel J;
Cancer; 2005 Oct; 104(8):1706-12. PubMed ID: 16134177
[TBL] [Abstract][Full Text] [Related]
12. Palliative chemotherapy in pretreated patients with advanced cancer: oral trofosfamide is effective in ovarian carcinoma.
Gunsilius E; Gierlich T; Mross K; Gastl G; Unger C
Cancer Invest; 2001; 19(8):808-11. PubMed ID: 11768034
[TBL] [Abstract][Full Text] [Related]
13. Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.
Al-Batran SE; Atmaca A; Bert F; Jäger D; Frisch C; Neumann A; Orth J; Knuth A; Jäger E
Onkologie; 2004 Dec; 27(6):534-8. PubMed ID: 15591711
[TBL] [Abstract][Full Text] [Related]
14. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
[TBL] [Abstract][Full Text] [Related]
15. Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma.
Witte HM; Riecke A; Mayer T; Bartscht T; Rades D; Lehnert H; Merz H; Fetscher S; Biersack H; Gebauer N
J Cancer Res Clin Oncol; 2019 Jan; 145(1):129-136. PubMed ID: 30327940
[TBL] [Abstract][Full Text] [Related]
16. Palliative chemotherapy with trofosfamide in advanced prostate cancer.
Salminen EK; Sundström J; Nikkanen V
Anticancer Res; 2006; 26(1B):539-42. PubMed ID: 16739316
[TBL] [Abstract][Full Text] [Related]
17. Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas: a Phase II trial by the Spanish Group for Research on Sarcomas (GEIS).
Maurel J; Fra J; López-Pousa A; García del Muro X; Balañá C; Casado A; Martín J; Martínez-Trufero J; de las Peñas R; Buesa JM;
Cancer; 2004 Apr; 100(7):1498-506. PubMed ID: 15042685
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule.
Serrone L; Zeuli M; Gamucci T; Nardi M; Cognetti F
Cancer Chemother Pharmacol; 2001 Mar; 47(3):206-10. PubMed ID: 11320663
[TBL] [Abstract][Full Text] [Related]
19. [Stabilizing the course of patients with stage IV advanced malignant melanoma by trofosfamide treatment].
Enk AH; Knop J
Hautarzt; 2000 Jul; 51(7):486-9. PubMed ID: 10969402
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II study of docetaxel, ifosfamide, and doxorubicin in advanced, recurrent, or metastatic soft tissue sarcoma (STS).
Suppiah R; Wood L; Elson P; Budd GT
Invest New Drugs; 2006 Nov; 24(6):509-14. PubMed ID: 16791410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
